| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Anesthesiology, and
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110
Sepsis induces extensive apoptosis in T and B cells suggesting that the loss of immune effector cells could be one explanation for the profound immunosuppression observed in this disorder. Unfortunately, the mechanisms responsible for lymphocyte apoptosis in sepsis remain unknown. In T cells, apoptosis can occur through activation-induced cell death (AICD) in which engagement of the Ag receptors by cognate Ag or polyclonal activators such as bacteria-derived superantigens induces activation, proliferation, and apoptosis. We examined whether proliferation and AICD are necessary for apoptotic cell death in sepsis using normal and TCR transgenic mice. Results show that although sepsis resulted in activation of a small percentage of T cells, no proliferation was detected during the first 48 h following onset, a time when extensive apoptosis is observed. We also observed that T cells do not enter the cell cycle, and stimulation via the TCR in TCR transgenic animals does not enhance or decrease cell death in sepsis. Interestingly, T cells recovered from septic mice retained their ability to proliferate and synthesize cytokines albeit at reduced levels. With the exception of IL-10, which was increased in lymphocytes from mice with sepsis, sepsis caused a decrease in the production of both proinflammatory and anti-inflammatory cytokines. We conclude that lymphocyte apoptosis in sepsis does not require proliferation, TCR engagement, or AICD. Thus the immunosuppression observed in sepsis cannot be the result of T cell deletion via the TCR.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by National Institutes of Health Grants EY06765 (to T.A.F.), EY015570 (to T.A.F.), and EY08972; Department of Ophthalmology and Visual Sciences CORE Grants GM44118 and GM55194 (to R.S.H.); and a Department of Ophthalmology and Visual Sciences grant from the Research to Prevent Blindness Foundation of New York.
2 Address correspondence and reprint requests to Dr. Thomas A. Ferguson, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 South Euclid, Box 8096, St. Louis, MO 63110. E-mail address: Ferguson{at}vision.wustl.edu
3 Abbreviations used in this paper: AICD, activation-induced cell death; CLP, cecal ligation and puncture.
This article has been cited by other articles:
|
|
 |
|
  J. Unsinger, H. Kazama, J. S. McDonough, R. S. Hotchkiss, and T. A. Ferguson Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury J. Leukoc. Biol., March 1, 2009; 85(3): 382 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tretter, R. K. C. Venigalla, V. Eckstein, R. Saffrich, S. Sertel, A. D. Ho, and H.-M. Lorenz Induction of CD4+ T-cell anergy and apoptosis by activated human B cells Blood, December 1, 2008; 112(12): 4555 - 4564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. O. Scumpia, M. J. Delano, K. M. Kelly-Scumpia, J. S. Weinstein, J. L. Wynn, R. D. Winfield, C. Xia, C. S. Chung, A. Ayala, M. A. Atkinson, et al. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis Blood, November 15, 2007; 110(10): 3673 - 3681. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
